Location: New York, NY
CIK: 0001825034 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $238M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VEU | VANGUARD INTL EQUITY INDEX F | 2,578,184 | $184M | 77.3% | $62.68 | — | ALLWRLD EX US | 922042775 |
| INDA | ISHARES TR | 369,600 | $19.24M | 8.1% | $42.12 | — | MSCI INDIA ETF | 46429B598 |
| ORIC | ORIC PHARMACEUTICALS INC | 989,410 | $11.87M | 5.0% | $23.68 | -55.6% | COM | 68622P109 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,573,761 | $7.696M | 3.2% | $16.74 | -68.3% | COM | 344174107 |
| ALEC | ALECTOR INC | 1,307,858 | $3.871M | 1.6% | $10.94 | -79.9% | COM | 014442107 |
| PMVP | PMV PHARMACEUTICALS INC | 2,627,643 | $3.679M | 1.5% | $35.52 | -96.1% | COM | 69353Y103 |
| SPY | SPDR S&P 500 ETF TR | 4,104 | $2.734M | 1.1% | $485.48 | — | TR UNIT | 78462F103 |
| RAPT | RAPT THERAPEUTICS INC | 82,234 | $2.121M | 0.9% | $7.63 | +71.5% | COM NEW | 75382E208 |
| TNYA | TENAYA THERAPEUTICS INC | 1,015,705 | $1.645M | 0.7% | $19.78 | -94.9% | COM | 87990A106 |
| SRZN | SURROZEN INC | 87,696 | $1.13M | 0.5% | $6.97 | +50.3% | COM NEW | 86889P208 |
| SRZNW | SURROZEN INC | 170,833 | $3,417 | 0.0% | $0.04 | — | *W EXP 08/01/203 | 86889P117 |